SCHEMBL29904689

SCHEMBL29904689

COc1nc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc3nccnc3c2P(C)(C)=O)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 11/20 0.63
▸ ALK Q9UM73 10/20 0.57
▸ INSR P06213 7/20 0.57
▸ IGF1R P08069 7/20 0.57
▸ ROS1 P08922 3/20 0.57
▸ CHEK1 O14757 1/20 0.57
▸ AURKA O14965 1/20 0.57
▸ NUAK1 O60285 1/20 0.57
▸ JAK2 O60674 1/20 0.57
▸ STK10 O94804 1/20 0.57
▸ PRKD3 O94806 1/20 0.57
▸ SLC34A2 O95436 1/20 0.57
▸ CHEK2 O96017 1/20 0.57
▸ ABL1 P00519 1/20 0.57
▸ CD74 P04233 1/20 0.57
▸ ERBB2 P04626 1/20 0.57
▸ LCK P06239 1/20 0.57
▸ FYN P06241 1/20 0.57
▸ FES P07332 1/20 0.57
▸ CSF1R P07333 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29114865 1.00 EGFR (0.63) EGFRALKINSRIGF1RROS1
SCHEMBL22595122 0.92 EGFR (0.75) EGFR
SCHEMBL25789201 0.90 EGFR (0.63) EGFRALK
SCHEMBL26906713 0.89 EGFR (0.67) EGFRALKINSRIGF1RROS1
SCHEMBL22028077 0.88 EGFR (0.76) EGFRALKINSRIGF1RROS1
SCHEMBL26906870 0.88 EGFR (0.60) EGFRALKINSRIGF1RROS1
SCHEMBL26907011 0.87 ALK (0.64) EGFRALKINSRIGF1RROS1
SCHEMBL29904627 0.87 ALK (0.64) EGFRALKINSRIGF1RROS1
SCHEMBL30659734 0.87 ALK (0.62) EGFRALKINSRIGF1RROS1
SCHEMBL26906900 0.87 EGFR (0.59) EGFRALKROS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022211573-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 테라펙스 2022-10-06 — — WO claimed
WO-2022211573-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 테라펙스 2022-10-06 — — WO disclosed
Send feedback